Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-35655
Bioorg Med Chem 2007 Feb 01;153:1409-19. doi: 10.1016/j.bmc.2006.11.004.
Show Gene links Show Anatomy links

Lead discovery and optimization of T-type calcium channel blockers.

Park JH , Choi JK , Lee E , Lee JK , Rhim H , Seo SH , Kim Y , Doddareddy MR , Pae AN , Kang J , Roh EJ .


???displayArticle.abstract???
A series of compounds were designed as T-type calcium channel blocker containing 6 or 5 pharmacophore features from structure-based virtual screening. To optimize the suggested structure, over 130 derivatives were synthesized and their inhibitory activities on T-type calcium channel were assayed using in vitro screening system with alpha1(G) and alpha1(H) clones. For the compounds with higher activities in FDSS assay system, the efficacy was measured by patch-clamp method. Among the library with 5 features, alkaneamide derivatives (7b, 9j, 11b, 11g, 11h) with 4-arylsubstituted piperazine showed better IC(50) values than Mibefradil.

???displayArticle.pubmedLink??? 17150365
???displayArticle.link??? Bioorg Med Chem